


Ask a doctor about a prescription for LOSARTAN/HYDROCHLOROTHIAZIDE MABO 50/12.5 mg FILM-COATED TABLETS
PACKAGE LEAFLET: INFORMATION FOR THE USER
Losartan/Hydrochlorothiazide Mabo 50mg/12.5mg film-coated tablets
Read all of this leaflet carefully before you start taking this medicine.
Contents of the pack and other information:
5 Storage of Losartan/Hydrochlorothiazide Mabo
Losartan/Hydrochlorothiazide Mabo is a combination of an angiotensin II receptor antagonist (losartan) and a diuretic (hydrochlorothiazide). Angiotensin II is a substance produced in the body that binds to receptors in blood vessels, causing them to narrow. This leads to an increase in blood pressure. Losartan prevents the binding of angiotensin II to these receptors, resulting in the relaxation of blood vessels, which in turn lowers blood pressure. Hydrochlorothiazide causes the kidneys to eliminate more water and salts. This also helps to reduce blood pressure.
Losartan/Hydrochlorothiazide Mabo is indicated for the treatment of essential hypertension (high blood pressure).
Do not takeLosartan/Hydrochlorothiazide Mabo
Warnings and precautions
Tell your doctor if you are pregnant (or think you might be). Your doctor will normally advise you to stop taking Losartan/Hydrochlorothiazide Mabo before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Losartan/Hydrochlorothiazide Mabo. Losartan/Hydrochlorothiazide Mabo is not recommended during the first trimester of pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby.
It is important that you inform your doctor before taking Losartan/Hydrochlorothiazide Mabo:
Your doctor may monitor your kidney function, blood pressure, and blood electrolyte levels (e.g. potassium) at regular intervals. See also the information under the heading “Do not take Losartan/Hydrochlorothiazide Mabo”.
Other medicines and Losartan/Hydrochlorothiazide Mabo
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including those obtained without a prescription.
Diuretics like hydrochlorothiazide in Losartan/Hydrochlorothiazide Mabo can interact with other medicines.
Preparations containing lithium should not be taken with Losartan/Hydrochlorothiazide Mabo without your doctor performing careful monitoring.
Special precautions may be necessary (e.g. blood tests) if you are taking potassium supplements, salt substitutes that contain potassium, or potassium-sparing medicines, diuretics (water tablets), some laxatives, medicines for treating gout, medicines for controlling heart rhythm or for diabetes (oral medicines or insulins).
It is also important that your doctor knows if you are taking:
Your doctor may need to change your dose and/or take other precautions:
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings “Do not take Losartan/Hydrochlorothiazide Mabo” and “Take special care with Losartan/Hydrochlorothiazide Mabo”).
Please, when taking Losartan/Hydrochlorothiazide Mabo, inform your doctor when you are scheduled to have a contrast medium with iodine.
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Losartan/Hydrochlorothiazide Mabo. Your doctor will decide whether to continue treatment. Do not stop taking Losartan/Hydrochlorothiazide Mabo on your own.
TakingLosartan/Hydrochlorothiazide Mabowith food and drinks
It is recommended that you do not drink alcohol while taking these tablets: alcohol and Losartan/Hydrochlorothiazide Mabo tablets may increase the effects of each other.
Excessive salt in your diet may counteract the effect of Losartan/Hydrochlorothiazide Mabo tablets.
Losartan/Hydrochlorothiazide Mabo can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You should inform your doctor if you are pregnant (or think you might be). Your doctor will normally advise you to stop taking Losartan/Hydrochlorothiazide Mabo before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Losartan/Hydrochlorothiazide Mabo. Losartan/Hydrochlorothiazide Mabo is not recommended during the first trimester of pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby.
Breastfeeding
Tell your doctor if you are breastfeeding or about to start breastfeeding. Losartan/Hydrochlorothiazide Mabo is not recommended during breastfeeding, and your doctor will choose another treatment for you if you want to breastfeed.
Consult your doctor or pharmacist before using any medicine.
Children and adolescents
There is no experience with the use of Losartan/Hydrochlorothiazide in children. Therefore, Losartan/Hydrochlorothiazide Mabo should not be given to children.
Use in elderly patients
Losartan/Hydrochlorothiazide Mabo works just as well and is just as well tolerated by most elderly patients and young adults. Most elderly patients require the same dose as younger patients.
Driving and using machines
When you start treatment with this medicine, you should not perform tasks that require special attention (e.g. driving a car or using hazardous machinery) until you know how your medicine affects you.
Use in athletes
This medicine contains hydrochlorothiazide, which may produce a positive result in doping tests.
Losartan/Hydrochlorothiazide Mabo contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Follow exactly the administration instructions of Losartan/Hydrochlorothiazide Mabo given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide the appropriate dose of Losartan/Hydrochlorothiazide Mabo, depending on your condition and whether you are taking other medicines. It is important to keep taking Losartan/Hydrochlorothiazide Mabo while your doctor prescribes it to maintain constant control of your blood pressure.
High blood pressure
For most patients with high blood pressure, the usual dose is 1 tablet of losartan/hydrochlorothiazide 50 mg/12.5 mg per day to control blood pressure over 24 hours. It can be increased to 2 film-coated tablets of losartan/hydrochlorothiazide 50 mg/12.5 mg per day or changed to 1 film-coated tablet of losartan/hydrochlorothiazide 100 mg/25 mg (a stronger dose) per day. The maximum daily dose is 2 tablets of 50 mg of losartan/12.5 mg of hydrochlorothiazide per day or 1 tablet of 100 mg of losartan/25 mg of hydrochlorothiazide per day.
If you take moreLosartan/Hydrochlorothiazide Mabothan you should
In case of overdose, contact your doctor immediately or go directly to the hospital for immediate medical attention.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.
Overdose may cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition, and dehydration.
If you forget to takeLosartan/Hydrochlorothiazide Mabo
Try to take Losartan/Hydrochlorothiazide Mabo as prescribed every day. However, if you miss a dose, do not take an extra dose. Simply return to your regular schedule.
Like all medicines, Losartan/Hydrochlorothiazide Mabo can cause side effects, although not everybody gets them.
If you experience the following, stop taking Losartan/Hydrochlorothiazide Mabo tablets and inform your doctor immediately or go to the casualty department of your nearest hospital:
A severe allergic reaction (skin rash, itching, swelling of the face, lips, mouth or throat that can cause difficulty in swallowing or breathing).
This is a serious but rare side effect, which affects more than 1 patient in 10,000 but less than 1 patient in 1,000. You may need urgent medical attention or hospitalization.
The following side effects have been reported:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people)
Frequency "not known" (frequency cannot be estimated from available data):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the reach and sight of children.
Do not use Losartan/Hydrochlorothiazide Mabo after the expiration date stated on the packaging after CAD. The expiration date is the last day of the indicated month.
Store Losartan/Hydrochlorothiazide Mabo in its original packaging.
Keep the blister pack in the outer packaging. Do not open the blister pack until you are ready to take the tablet.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition ofLosartan/Hydrochlorothiazide Mabo
The active ingredients are losartan potassium and hydrochlorothiazide.
Each Losartan/Hydrochlorothiazide Mabo tablet contains, as active ingredients, 50 mg of losartan (potassium) and 12.5 mg of hydrochlorothiazide.
Losartan/Hydrochlorothiazide Mabo contains the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, pregelatinized corn starch, magnesium stearate.
Losartan/Hydrochlorothiazide Mabo 50 mg/12.5 mg contains 4.24 mg (0.108 mEq) of potassium.
Losartan/Hydrochlorothiazide Mabo also contains hydroxypropyl cellulose (hypromellose), hydroxypropyl methylcellulose (hypromellose), titanium dioxide (E-171), talc, yellow iron oxide (E-172).
Appearance of the product and package contents
Losartan/Hydrochlorothiazide Mabo is supplied as film-coated tablets of yellow color, elongated and with a score line on one side.
Losartan/Hydrochlorothiazide Mabo is supplied in the following package sizes:
Al/PVC/PE/PVDC blister packs in packages of 28 tablets.
Marketing authorization holder
MABO-FARMA S.A.
Vía de los Poblados Street, 3,
Building 6, 28033 Madrid,
Spain.
Manufacturer
Meiji Pharma Spain S.A.
Avda. de Madrid 94 Alcala de Henares (Madrid) - 28802 – Spain
Date of the last revision of this leaflet:February 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LOSARTAN/HYDROCHLOROTHIAZIDE MABO 50/12.5 mg FILM-COATED TABLETS in November, 2025 is around 2.92 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LOSARTAN/HYDROCHLOROTHIAZIDE MABO 50/12.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.